BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 7, Issue 27
This Article
Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (10402)
All Articles published online
The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.
Item 
Count 
PDF478
WORD315
HTML4581
Figures (1-1)283
Tables (1-2)281
 Sum=5938
Featured Article
The chart showing Browse series, Download series.
Item 
Count 
Browse529
Download1221
 Sum=1750
Publishing Process of This Article
The chart showing Browse series, Download series.
Item 
Count 
Browse1186
Download1528
 Sum=2714
Nov 28, 2015 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Hirten R, Sultan K, Thomas A, Bernstein DE. Hepatic manifestations of non-steroidal inflammatory bowel disease therapy. World J Hepatol 2015; 7(27): 2716-2728 [PMID: PMC4663391 DOI: 10.4254/wjh.v7.i27.2716]
URL: https://www.wjgnet.com/1948-5182/full/v7/i27/2716.htm
Number Citing Articles
1
Sophie Restellini, Olivier Chazouillères, Jean‐Louis Frossard. Hepatic manifestations of inflammatory bowel diseases. Liver International 2017; 37(4): 475 doi: 10.1111/liv.13265
2
Patrick R. Wood, Liron Caplan. Drug-Induced Gastrointestinal and Hepatic Disease Associated with Biologics and Nonbiologic Disease-Modifying Antirheumatic Drugs. Rheumatic Disease Clinics of North America 2018; 44(1): 29 doi: 10.1016/j.rdc.2017.09.003
3
Nazli Begum Ozturk, Maria Isabel Fiel, Thomas D. Schiano. Identification and clinical significance of nodular regenerative hyperplasia in primary sclerosing cholangitis. JGH Open 2022; 6(9): 607 doi: 10.1002/jgh3.12795
4
Yan Gong, Yishu He, Mengting Wan, Hong Chen. Risk Factors for Gallstones in Crohn’s Disease: A Systematic Review and Meta-Analysis. Digestive Diseases and Sciences 2024; 69(11): 4187 doi: 10.1007/s10620-024-08597-1
5
Kwang Il Seo, Sang-Bum Kang. Hepatobiliary Manifestation of Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2019; 73(5): 248 doi: 10.4166/kjg.2019.73.5.248
6
Stefano Mazza, Sara Soro, Maria Chiara Verga, Biagio Elvo, Francesca Ferretti, Fabrizio Cereatti, Andrea Drago, Roberto Grassia. Liver-side of inflammatory bowel diseases: Hepatobiliary and drug-induced disorders. World Journal of Hepatology 2021; 13(12): 1828-1849 doi: 10.4254/wjh.v13.i12.1828
7
Yoshiki Seto, Kouki Kato, Ryota Tsukada, Hiroki Suzuki, Yuuki Kaneko, Yoshiki Kojo, Hideyuki Sato, Satomi Onoue. Protective effects of tranilast on experimental colitis in rats. Biomedicine & Pharmacotherapy 2017; 90: 842 doi: 10.1016/j.biopha.2017.04.035
8
Akshay Patel, Andras Perl. Redox Control of Integrin-Mediated Hepatic Inflammation in Systemic Autoimmunity. Antioxidants & Redox Signaling 2022; 36(7-9): 367 doi: 10.1089/ars.2021.0068
9
Mohammad Aadil Bhat, Supriya Roy, Suneela Dhaneshwar, Swatantra Kumar, Shailendra K. Saxena. Desloratadine via its anti-inflammatory and antioxidative properties ameliorates TNBS-induced experimental colitis in rats . Immunopharmacology and Immunotoxicology 2024; 46(4): 436 doi: 10.1080/08923973.2024.2360043
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345